JASVINDER SINGH to Pain Measurement
This is a "connection" page, showing publications JASVINDER SINGH has written about Pain Measurement.
Connection Strength
3.206
-
Consensus on draft OMERACT core domains for clinical trials of Total Joint Replacement outcome by orthopaedic surgeons: a report from the International consensus on outcome measures in TJR trials (I-COMiTT) group. BMC Musculoskelet Disord. 2017 01 26; 18(1):45.
Score: 0.481
-
Reliability and clinically important improvement thresholds for osteoarthritis pain and function scales: a multicenter study. J Rheumatol. 2014 Mar; 41(3):509-15.
Score: 0.390
-
OMERACT endorsement of measures of outcome for studies of acute gout. J Rheumatol. 2014 Mar; 41(3):569-73.
Score: 0.387
-
Which factors predict discordance between a patient and physician on a gout flare? Rheumatology (Oxford). 2021 02 01; 60(2):773-779.
Score: 0.159
-
Association of Early Postoperative Pain Trajectories With Longer-term Pain Outcome After Primary Total Knee Arthroplasty. JAMA Netw Open. 2019 11 01; 2(11):e1915105.
Score: 0.146
-
Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018. J Rheumatol. 2019 10; 46(10):1355-1359.
Score: 0.140
-
Patient Endorsement of the Outcome Measures in Rheumatology (OMERACT) Total Joint Replacement (TJR) clinical trial draft core domain set. BMC Musculoskelet Disord. 2017 03 15; 18(1):111.
Score: 0.121
-
Chondroitin for osteoarthritis. Cochrane Database Syst Rev. 2015 Jan 28; 1:CD005614.
Score: 0.105
-
Application of the OMERACT filter to measures of core outcome domains in recent clinical studies of acute gout. J Rheumatol. 2014 Mar; 41(3):574-80.
Score: 0.097
-
Patient-level clinically meaningful improvements in activities of daily living and pain after total hip arthroplasty: data from a large US institutional registry. Rheumatology (Oxford). 2013 Jun; 52(6):1109-18.
Score: 0.091
-
Medical and psychological comorbidity predicts poor pain outcomes after total knee arthroplasty. Rheumatology (Oxford). 2013 May; 52(5):916-23.
Score: 0.091
-
Risk factors for revision surgery after humeral head replacement: 1,431 shoulders over 3 decades. J Shoulder Elbow Surg. 2012 Aug; 21(8):1039-44.
Score: 0.083
-
Validation of pain and patient global scales in chronic gout: data from two randomised controlled trials. Ann Rheum Dis. 2011 Jul; 70(7):1277-81.
Score: 0.082
-
Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol. 2011 Jul; 38(7):1452-7.
Score: 0.082
-
Botulinum toxin for shoulder pain: a cochrane systematic review. J Rheumatol. 2011 Mar; 38(3):409-18.
Score: 0.079
-
Intraarticular botulinum toxin A for refractory painful total knee arthroplasty: a randomized controlled trial. J Rheumatol. 2010 Nov; 37(11):2377-86.
Score: 0.077
-
Anakinra for rheumatoid arthritis: a systematic review. J Rheumatol. 2009 Jun; 36(6):1118-25.
Score: 0.070
-
Can patients help with long-term total knee arthroplasty surveillance? Comparison of the American Knee Society Score self-report and surgeon assessment. Rheumatology (Oxford). 2009 Feb; 48(2):160-4.
Score: 0.069
-
Intra-articular botulinum toxin A as an adjunctive therapy for refractory joint pain in patients with rheumatoid arthritis receiving biologics: a report of two cases. Joint Bone Spine. 2009 Mar; 76(2):190-4.
Score: 0.068
-
Benefit-risk assessment and reporting in clinical trials of chronic pain treatments: IMMPACT recommendations. Pain. 2022 06 01; 163(6):1006-1018.
Score: 0.041
-
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations. Pain. 2020 11; 161(11):2446-2461.
Score: 0.039
-
Shoulder replacement surgery for osteoarthritis and rotator cuff tear arthropathy. Cochrane Database Syst Rev. 2020 04 21; 4:CD012879.
Score: 0.038
-
Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial. Clin Rheumatol. 2017 Jun; 36(6):1357-1367.
Score: 0.030
-
Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations. Pain. 2016 Sep; 157(9):1836-1850.
Score: 0.029
-
Outcome measures in acute gout: a systematic literature review. J Rheumatol. 2014 Mar; 41(3):558-68.
Score: 0.024
-
Does clinically important change in function after knee replacement guarantee good absolute function? The multicenter osteoarthritis study. J Rheumatol. 2014 Jan; 41(1):60-4.
Score: 0.024
-
Participation following knee replacement: the MOST cohort study. Phys Ther. 2013 Nov; 93(11):1467-74.
Score: 0.023
-
The influence of the contralateral knee prior to knee arthroplasty on post-arthroplasty function: the multicenter osteoarthritis study. J Bone Joint Surg Am. 2013 Jun 05; 95(11):989-93.
Score: 0.023
-
Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: evidence from phase III randomized controlled trials. J Rheumatol. 2012 Jul; 39(7):1450-7.
Score: 0.022
-
OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 Special Interest Group. J Rheumatol. 2011 Aug; 38(8):1765-9.
Score: 0.021
-
Minimally important differences of the gout impact scale in a randomized controlled trial. Rheumatology (Oxford). 2011 Jul; 50(7):1331-6.
Score: 0.020
-
The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement. Osteoarthritis Cartilage. 2011 Feb; 19(2):147-54.
Score: 0.019
-
Intra-articular Botulinum Toxin Type A: a new approach to treat arthritis joint pain. Toxicon. 2009 Oct; 54(5):658-67.
Score: 0.017
-
Perceptions of disease and health-related quality of life among patients with gout. Rheumatology (Oxford). 2009 May; 48(5):582-6.
Score: 0.017